Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). (Q40108266)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). |
scientific article |
Statements
1 reference
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). (English)
1 reference
I Vergote
1 reference
N S Reed
1 reference
C Mangioni
1 reference
H Malmström
1 reference
G Scarfone
1 reference
A Poveda
1 reference
S Pecorelli
1 reference
S Tateo
1 reference
J J Jobsen
1 reference
C Coens
1 reference
I Teodorovic
1 reference
J B Vermorken
1 reference
European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group
1 reference
2 April 2008
1 reference
1 reference
Identifiers
1 reference